Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jul '25 Jul 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	961	597	729	146	161	359	Upgrade
Market Cap Growth	18.18%	-18.18%	400.02%	-9.63%	-55.00%	224469.36%	Upgrade
Enterprise Value	962	597	729	146	162	359	Upgrade
Last Close Price	6.10	4.50	5.50	1.10	4.95	11.00	Upgrade
PE Ratio	500.53	1544.93	598.85	192.40	-	-	Upgrade
PS Ratio	189.63	152.23	324.27	93.35	-	-	Upgrade
PB Ratio	40.21	134.00	174.74	188.80	-467.12	-1360.01	Upgrade
P/TBV Ratio	42.90	208.85	346.83	189.09	-	-	Upgrade
P/FCF Ratio	-	-	3904.43	-	3259.28	130040.97	Upgrade
P/OCF Ratio	6129.40	-	3625.43	11612.71	3176.65	130040.97	Upgrade
EV/Sales Ratio	189.78	152.23	324.32	93.38	-	-	Upgrade
EV/EBITDA Ratio	-	424.46	409.30	192.37	-	-	Upgrade
EV/EBIT Ratio	-	614.63	431.46	192.47	-	-	Upgrade
EV/FCF Ratio	-6214.82	-	3905.08	-	3265.97	130136.74	Upgrade
Debt / Equity Ratio	0.04	0.02	0.04	0.10	-0.98	-1.01	Upgrade
Debt / EBITDA Ratio	0.28	0.05	0.09	0.10	-	-	Upgrade
Debt / FCF Ratio	-	-	0.86	-	6.83	96.76	Upgrade
Asset Turnover	0.25	0.58	0.65	2.38	-	-	Upgrade
Quick Ratio	0.86	1.68	1.58	0.35	0.13	0.01	Upgrade
Current Ratio	1.86	1.75	2.30	2.60	0.14	0.02	Upgrade
Return on Equity (ROE)	13.42%	8.96%	49.24%	355.03%	-	-	Upgrade
Return on Assets (ROA)	7.74%	8.95%	30.33%	72.14%	-164.38%	-	Upgrade
Return on Capital (ROIC)	10.36%	13.69%	40.77%	112.40%	-	-	Upgrade
Return on Capital Employed (ROCE)	10.40%	21.60%	40.20%	98.10%	-	-	Upgrade
Earnings Yield	0.20%	0.07%	0.17%	0.52%	-0.05%	-0.10%	Upgrade
FCF Yield	-0.02%	-0.07%	0.03%	-0.03%	0.03%	0.00%	Upgrade
Buyback Yield / Dilution	28.82%	27.25%	-19.83%	-624.63%	-162.13%	-12361.86%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.